Annual Short Term Debt
$3.54 M
-$649.00 K-15.50%
31 December 2023
Summary:
Achilles Therapeutics annual short term debt is currently $3.54 million, with the most recent change of -$649.00 thousand (-15.50%) on 31 December 2023. During the last 3 years, it has fallen by -$173.00 thousand (-4.66%). ACHL annual short term debt is now -21.04% below its all-time high of $4.48 million, reached on 31 December 2021.ACHL Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$3.62 M
-$585.00 K-13.91%
01 September 2024
Summary:
Achilles Therapeutics quarterly short term debt is currently $3.62 million, with the most recent change of -$585.00 thousand (-13.91%) on 01 September 2024. Over the past year, it has dropped by -$1.00 million (-21.65%). ACHL quarterly short term debt is now -22.48% below its all-time high of $4.67 million, reached on 31 March 2022.ACHL Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHL Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -15.5% | -21.6% |
3 y3 years | -4.7% | -17.7% |
5 y5 years | - | - |
ACHL Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -21.0% | at low | -22.5% | +2.3% |
5 y | 5 years | -21.0% | +626.7% | -22.5% | +2.3% |
alltime | all time | -21.0% | +626.7% | -22.5% | +2.3% |
Achilles Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $3.62 M(-13.9%) |
June 2024 | - | $4.21 M(+15.9%) |
Mar 2024 | - | $3.63 M(+2.5%) |
Dec 2023 | $3.54 M(-15.5%) | $3.54 M(-23.4%) |
Sept 2023 | - | $4.62 M(-0.8%) |
June 2023 | - | $4.66 M(+15.3%) |
Mar 2023 | - | $4.04 M(-3.6%) |
Dec 2022 | $4.19 M | $4.19 M(+3.8%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $4.04 M(-9.9%) |
June 2022 | - | $4.48 M(-4.1%) |
Mar 2022 | - | $4.67 M(+4.2%) |
Dec 2021 | $4.48 M(+20.7%) | $4.48 M(+1.9%) |
Sept 2021 | - | $4.40 M(-5.6%) |
June 2021 | - | $4.66 M(+1.1%) |
Mar 2021 | - | $4.61 M(+24.2%) |
Dec 2020 | $3.71 M(+662.2%) | $3.71 M |
Dec 2019 | $487.00 K | - |
FAQ
- What is Achilles Therapeutics annual short term debt?
- What is the all time high annual short term debt for Achilles Therapeutics?
- What is Achilles Therapeutics annual short term debt year-on-year change?
- What is Achilles Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Achilles Therapeutics?
- What is Achilles Therapeutics quarterly short term debt year-on-year change?
What is Achilles Therapeutics annual short term debt?
The current annual short term debt of ACHL is $3.54 M
What is the all time high annual short term debt for Achilles Therapeutics?
Achilles Therapeutics all-time high annual short term debt is $4.48 M
What is Achilles Therapeutics annual short term debt year-on-year change?
Over the past year, ACHL annual short term debt has changed by -$649.00 K (-15.50%)
What is Achilles Therapeutics quarterly short term debt?
The current quarterly short term debt of ACHL is $3.62 M
What is the all time high quarterly short term debt for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly short term debt is $4.67 M
What is Achilles Therapeutics quarterly short term debt year-on-year change?
Over the past year, ACHL quarterly short term debt has changed by -$1.00 M (-21.65%)